Delivery Order SPE2DB25D3306-SPE2DB25FUCMF
Award Date 8/1/25
Potential Completion Date 8/4/25
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injectors with a ceiling value of $16,289.67 under firm fixed-price terms. The contract is set to be completed by August 6, 2025, with the place of performance located in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order issued as a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,435.40 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen injectors on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a non-competitive award under DLA's existing Indefinite Delivery Contract (IDC) with AmerisourceBergen, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026. The contract is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,155.44 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injectors, a medication used in diabetes and weight management treatment. This firm fixed-price delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,814.18 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract issued under a...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.96 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen injectors on July 28, 2025, with completion scheduled for July 29, 2025. This is a firm fixed-price delivery order issued under a non-competitive set-aside arrangement, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single-transaction delivery of this diabetes medication to support federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with a ceiling value of $1,143.87 and an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the government's procurement of this diabetes medication through AmerisourceBergen's existing pharmaceutical supply contracts. The...
- The Defense Logistics Agency awarded a delivery order valued at $42,252.91 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors on June 30, 2025, with an ultimate completion date of July 1, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The performance location for...
- The Defense Logistics Agency awarded a delivery order valued at $29,615.89 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on July 28, 2025, with an ultimate completion date of July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a single delivery order transaction for the diabetes medication. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors with a ceiling value of $16,361.85. This firm fixed-price contract, which expires August 21, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made through competitive procedures with no set-aside designation, and performance...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 10 mg/0.5 ml pen injections in 0.5 ml quantities. This firm fixed-price delivery order, valued at $33,707.47, represents a non-competitive set-aside and is scheduled for completion by August 5, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, serving the military healthcare supply chain through DLA Medical Supply...